Chiral azodipyrrole and application thereof to preparation of drug for inhibiting pathogenic bacteria infection
A technology of heterodipyrrole and pathogenic bacteria, applied in the field of chiral azadipyrrole antibacterial drugs and its application, can solve problems such as bacterial infection, life-threatening of patients, sepsis, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] A kind of chiral azadipyrrole is prepared by the following method:
[0030] 1) Compound 2 (10mmol, 3.4g) was dissolved in CH 2 Cl 2 (50mL), add CH 3 OCH 2 Cl (12mmol, 0.8g), i- PR 2 NEt (catalyst), at 25°C, reacted for 1 h, monitored by TLC, separated by extraction and separated by column chromatography to obtain compound 3a (3.64 g, yield 95%).
[0031] 2) Will 10mmol, 2.83g) was dissolved in THF (50mL), adding compound 3a (0.8mmol, 3.07g), NaHCO 3 (10mmol, 0.84g), stirred at room temperature for 1h, monitored by TLC, extracted and separated, separated by column chromatography, concentrated for later use;
[0032] 3) Dissolve the concentrate obtained in step (2) in methanol (50mL), add a catalytic amount of HCl dropwise, 50°C, 10min, extract and separate, and separate by column chromatography to obtain compound I-5 (4.71g, 96% ). 1H NMR (300MHz, CDCl3)δ
[0033] 7.16-7.26(m, 2H), 7.11(d, J=8.7Hz, 1H), 6.78-6.86(m, 2H), 6.98(dd, J=8.7, 6.2Hz, 1H), 6.23(dd, J=...
Embodiment 2
[0035] A kind of chiral azadipyrrole is prepared by the following method:
[0036] 1) with Alternative to Example 1 Other is with embodiment 1, obtains compound I-6
[0037] (4.71 g, 96%).
Embodiment 3
[0039] A kind of chiral azadipyrrole is prepared by the following method:
[0040] 1) Compound 2 (10mmol, 3.4g) was dissolved in CH 2 Cl 2 (50mL), add CH 3 OCH 2 Cl (12mmol, 0.8g), i- PR 2 NEt (catalyst), at 25°C, reacted for 1 h, monitored by TLC, separated by extraction and separated by column chromatography to obtain compound 3a (3.64 g, yield 95%). ;
[0041] 2) Will ( 10mmol, 2.83g) was dissolved in THF (50mL), adding compound 3a (0.8mmol, 3.07g), NaHCO 3 (10mmol, 0.84g), stirred at room temperature for 1h, monitored by TLC, separated by extraction, concentrated by drying, and separated by column chromatography to obtain compound I-8 (4.57g, 80%).
[0042] 3) Dissolve the concentrate obtained in step (2) in methanol (50mL), add a catalytic amount of HCl dropwise, 50°C, 10min, extract and separate, and separate by column chromatography to obtain compound I-7 (4.85g, 98% ).
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com